Point-of-Care Laboratory Tests Available via Finger-Stick Sampling
Finger-stick (capillary) blood samples can reliably measure glucose, hemoglobin A1C, HIV viral load, cryptococcal antigen, SARS-CoV-2 antibodies, clozapine levels, and tuberculosis biomarkers at the point-of-care, with glucose and A1C being the most established and widely used tests.
Established Point-of-Care Tests
Glucose Monitoring
Glucose meters using finger-stick samples are the most common point-of-care test, though they are less accurate than laboratory methods. More than 95% of readings should be within ±15 mg/dL for glucose <75 mg/dL, and within 20% for higher values 1. The accuracy depends heavily on proper technique—operator errors exceed instrument errors. Common pitfalls include:
- Failure to calibrate meters regularly
- Poor hand washing before testing
- Improper strip storage (humidity/temperature exposure)
- Testing from alternate sites (forearm, thigh) during rapidly changing glucose states
Fingertip testing is mandatory when glucose is changing rapidly (post-meal, during exercise, or with insulin treatment), as alternate sites lag behind actual glucose changes 1.
Hemoglobin A1C
Point-of-care A1C assays are FDA-cleared and NGSP-certified for use in both CLIA-regulated and CLIA-waived settings 2. However, plasma glucose criteria should be used instead of A1C in conditions with altered red blood cell turnover: pregnancy (second/third trimesters and postpartum), hemoglobin variants, G6PD deficiency, HIV, hemodialysis, recent blood loss/transfusion, or erythropoietin therapy 2.
Emerging and Specialized Point-of-Care Tests
Infectious Disease Testing
HIV Viral Load: Finger-prick samples achieve 100% concordance with laboratory methods when including a simple 3-minute microcentrifuge spin before testing with Cepheid Xpert assays. Without centrifugation, accuracy is poor for undetectable viral loads 3.
Cryptococcal Antigen: The CRAG lateral flow assay shows 100% agreement between fingerstick whole blood and serum/plasma, with 100% sensitivity for cryptococcal meningitis 4.
SARS-CoV-2 Antibodies: IgM-IgG combined tests on capillary whole blood demonstrate 100% specificity, with sensitivity increasing from 10-35% at 0-5 days post-symptom onset to 100% after 15 days 5.
Tuberculosis Triage: The 3-host protein multibiomarker test achieved 91.4% sensitivity and 73.2% specificity, meeting WHO target product profile for triage testing 6.
Therapeutic Drug Monitoring
Clozapine concentrations measured from finger-stick samples show strong correlation (R=0.89) with venous samples, with results available within 6 minutes using MyCare™ Insite analyzer 7.
Critical Implementation Considerations
Education is paramount—patient training significantly reduces user-related inaccuracies, which are the primary source of error in point-of-care testing 1. For glucose monitoring specifically, ensure patients understand:
- Proper calibration schedules
- Hand hygiene requirements
- Appropriate site selection based on clinical context
- Drug interferences (ascorbic acid, acetaminophen, dopamine, mannitol)
Hematocrit affects glucose readings: low hematocrit falsely increases results because erythrocytes are relatively glucose-poor, and most meters assume normal hematocrit when calibrated to provide plasma-equivalent readings 1.